Target Name: MIR1305
NCBI ID: G100302270
Review Report on MIR1305 Target / Biomarker Content of Review Report on MIR1305 Target / Biomarker
MIR1305
Other Name(s): hsa-miR-1305 | MicroRNA 1305 | mir-1305 | MIRN1305 | hsa-mir-1305 | microRNA 1305

MIR1305: A Potential Drug Target and Biomarker

MIR1305 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR family of non-coding RNAs, which have been shown to play important roles in a variety of biological processes. One of the most promising aspects of MIR1305 is its potential as a drug target and biomarker.

The MIR family of non-coding RNAs has been shown to play important roles in a variety of processes, including cell signaling, tissue repair, and stress response. MIR1305 is a member of this family and has been shown to participate in several important biological processes.

One of the most promising aspects of MIR1305 is its potential as a drug target. MIR1305 has been shown to interact with several different proteins, including the transcription factor NF-kappa-B. This suggests that MIR1305 may be a useful target for drugs that are designed to modulate the activity of these proteins.

In addition to its potential as a drug target, MIR1305 has also been shown to be a potential biomarker. The MIR1305 gene has been shown to be highly expressed in a variety of tissues, including the brain, heart, and kidneys. This suggests that MIR1305 may be a useful biomarker for a variety of diseases, including neurodegenerative disorders, cardiovascular disease, and kidney disease.

In conclusion, MIR1305 is a protein that has the potential to be a drug target and biomarker. Further research is needed to fully understand the role of MIR1305 in biological processes and to develop drugs that can modulate its activity.

Protein Name: MicroRNA 1305

The "MIR1305 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1305 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1